Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases
DNA topoisomerases are important cellular enzymes found in almost all types of living cells (eukaryotic and prokaryotic). These enzymes are essential for various DNA metabolic processes e.g. replication, transcription, recombination, chromosomal decatenation etc. These enzymes are important molecular drug targets and inhibitors of these enzymes are widely used as effective anticancer and antibacterial drugs. However, topoisomerase inhibitors have some therapeutic limitations and they exert serious side effects during cancer chemotherapy. Thus, development of novel anticancer topoisomerase inhibitors is necessary for improving cancer chemotherapy. Nature serves as a repertoire of structurally and chemically diverse molecules and in the recent years many DNA topoisomerase inhibitors have been identified from natural sources. The present review discusses anticancer properties and therapeutic importance of eighteen recently identified natural topoisomerase inhibitors (from the year 2009 to 2015). Structural characteristics of these novel inhibitors provide backbones for designing and developing new anticancer drugs.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Current genomics - 18(2017), 1 vom: 01. Feb., Seite 75-92 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jain, Chetan Kumar [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anticancer agents |
|---|
| Anmerkungen: |
Date Revised 25.03.2024 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.2174/1389202917666160808125213 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM27187953X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM27187953X | ||
| 003 | DE-627 | ||
| 005 | 20240325233908.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1389202917666160808125213 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1346.xml |
| 035 | |a (DE-627)NLM27187953X | ||
| 035 | |a (NLM)28503091 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jain, Chetan Kumar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 25.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a DNA topoisomerases are important cellular enzymes found in almost all types of living cells (eukaryotic and prokaryotic). These enzymes are essential for various DNA metabolic processes e.g. replication, transcription, recombination, chromosomal decatenation etc. These enzymes are important molecular drug targets and inhibitors of these enzymes are widely used as effective anticancer and antibacterial drugs. However, topoisomerase inhibitors have some therapeutic limitations and they exert serious side effects during cancer chemotherapy. Thus, development of novel anticancer topoisomerase inhibitors is necessary for improving cancer chemotherapy. Nature serves as a repertoire of structurally and chemically diverse molecules and in the recent years many DNA topoisomerase inhibitors have been identified from natural sources. The present review discusses anticancer properties and therapeutic importance of eighteen recently identified natural topoisomerase inhibitors (from the year 2009 to 2015). Structural characteristics of these novel inhibitors provide backbones for designing and developing new anticancer drugs | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Anticancer agents | |
| 650 | 4 | |a DNA topoisomerases | |
| 650 | 4 | |a Natural products | |
| 650 | 4 | |a Topoisomerase inhibitors | |
| 700 | 1 | |a Majumder, Hemanta Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Roychoudhury, Susanta |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current genomics |d 2000 |g 18(2017), 1 vom: 01. Feb., Seite 75-92 |w (DE-627)NLM167104853 |x 1389-2029 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2017 |g number:1 |g day:01 |g month:02 |g pages:75-92 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1389202917666160808125213 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2017 |e 1 |b 01 |c 02 |h 75-92 | ||